78
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Medical management of recurrent endometrioma with long-term norethindrone acetate

, , , , , , & show all
Pages 149-154 | Published online: 30 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michele Vignali, Gaia Maria Belloni, Giuliana Pietropaolo, Allegra Barbasetti Di Prun, Valeria Barbera, Stefano Angioni & Ida Pino. (2020) Effect of Dienogest therapy on the size of the endometrioma. Gynecological Endocrinology 36:8, pages 723-727.
Read now
Giuseppe Benagiano, Sun-Wei Guo, Paola Bianchi, Patrick Puttemans, Stephan Gordts, Felice Petraglia & Ivo Brosens. (2016) Pharmacologic treatment of the ovarian endometrioma. Expert Opinion on Pharmacotherapy 17:15, pages 2019-2031.
Read now
Emanuela Tafi, Umberto Leone Roberti Maggiore, Franco Alessandri, Stefano Bogliolo, Barbara Gardella, Valerio Gaetano Vellone, Federica Grillo, Luca Mastracci & Simone Ferrero. (2015) Advances in pharmacotherapy for treating endometriosis. Expert Opinion on Pharmacotherapy 16:16, pages 2465-2483.
Read now
Nicolò Bizzarri, Valentino Remorgida, Umberto Leone Roberti Maggiore, Carolina Scala, Emanuela Tafi, Valentina Ghirardi, Stefano Salvatore, Massimo Candiani, Pier Luigi Venturini & Simone Ferrero. (2014) Dienogest in the treatment of endometriosis. Expert Opinion on Pharmacotherapy 15:13, pages 1889-1902.
Read now

Articles from other publishers (15)

Pietro Bortoletto & Meridith Pollie. (2021) Management of Ovarian Endometrioma in Asymptomatic Reproductive Age Women. Current Obstetrics and Gynecology Reports 10:4, pages 53-60.
Crossref
Simona Del Forno, Maria Cofano, Eugenia Degli Esposti, Federica Manzara, Jacopo Lenzi, Diego Raimondo, Alessandro Arena, Roberto Paradisi, Paolo Casadio & Renato Seracchioli. (2021) Long-Term Medical Therapy after Laparoscopic Excision of Ovarian Endometriomas: Can We Reduce and Predict the Risk of Recurrence?. Gynecologic and Obstetric Investigation 86:1-2, pages 170-176.
Crossref
Federica Visconti & Costantino Di Carlo. 2021. Endometriosis Pathogenesis, Clinical Impact and Management. Endometriosis Pathogenesis, Clinical Impact and Management 65 71 .
Matityahu Zolti & Howard J. A. Carp. 2021. Progestogens in Obstetrics and Gynecology. Progestogens in Obstetrics and Gynecology 137 156 .
Bogdan Doroftei, Theodora Armeanu, Radu Maftei, Ovidiu-Dumitru Ilie, Ana-Maria Dabuleanu & Constantin Condac. (2020) Abdominal Wall Endometriosis: Two Case Reports and Literature Review. Medicina 56:12, pages 727.
Crossref
Simona Del Forno, Mohamed Mabrouk, Alessandro Arena, Giulia Mattioli, Ilaria Giaquinto, Roberto Paradisi & Renato Seracchioli. (2019) Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?. European Journal of Obstetrics & Gynecology and Reproductive Biology 238, pages 120-124.
Crossref
Akemi Koshiba, Taisuke Mori, Hiroyuki Okimura, Kanoko Akiyama, Hisashi Kataoka, Osamu Takaoka, Fumitake Ito, Hiroshi Matsushima, Izumi Kusuki & Jo Kitawaki. (2018) Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. Journal of Obstetrics and Gynaecology Research.
Crossref
Paolo Vercellini, Agnese Donati, Federica Ottolini, Annalisa Frassineti, Jessica Fiorini, Vanessa Nebuloni, Maria Pina Frattaruolo, Anna Roberto, Paola Mosconi & Edgardo Somigliana. (2018) A stepped-care approach to symptomatic endometriosis management: a participatory research initiative. Fertility and Sterility 109:6, pages 1086-1096.
Crossref
Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio, Anna Roberto & Edgardo Somigliana. (2018) Is Shifting to a Progestin Worthwhile When Estrogen—Progestins Are Inefficacious for Endometriosis-Associated Pain?. Reproductive Sciences 25:5, pages 674-682.
Crossref
Paolo Vercellini, Federica Ottolini, Maria Pina Frattaruolo, Laura Buggio, Anna Roberto & Edgardo Somigliana. (2018) Shifting from Oral Contraceptives to Norethisterone Acetate, or Vice Versa, because of Drug Intolerance: Does the Change Benefit Women with Endometriosis?. Gynecologic and Obstetric Investigation 83:3, pages 275-284.
Crossref
Paolo Vercellini, Benedetta Bracco, Paola Mosconi, Anna Roberto, Daniela Alberico, Dridi Dhouha & Edgardo Somigliana. (2016) Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertility and Sterility 105:3, pages 734-743.e3.
Crossref
U. Leone Roberti Maggiore, C. Scala, P.L. Venturini, V. Remorgida & S. Ferrero. (2015) Endometriotic ovarian cysts do not negatively affect the rate of spontaneous ovulation. Human Reproduction 30:2, pages 299-307.
Crossref
Howard J. A. Carp, David Soriano & Matityahu Zolti. 2015. Progestogens in Obstetrics and Gynecology. Progestogens in Obstetrics and Gynecology 129 147 .
Simone Ferrero, Valentino Remorgida, Pier Luigi Venturini & Umberto Leone Roberti Maggiore. (2014) Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study. European Journal of Obstetrics & Gynecology and Reproductive Biology 174, pages 117-122.
Crossref
Kari Hilde Juvkam & Hilde Beate Gudim. (2013) Medikamentell forskyvning av menstruasjon. Tidsskrift for Den norske legeforening 133:2, pages 166-168.
Crossref